| Product Name | Ibrutinib (Synonyms: PCI-32765) |
|---|---|
| CAS | 936563-96-1 |
| Formula | C25H24N6O2 |
| MW | 440.51 |
| Appearance | White powder |
| Storage condition | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). |
| Size | Availability | Price(USD) | VIP Price (USD) | Quantity |
|---|---|---|---|---|
| 200 mg | In-stock | ¥200.00 | Visible after login | |
| 500 mg | In-stock | ¥320.00 | Visible after login | |
| 1 g | In-stock | ¥500.00 | Visible after login |
| Product Name | Ibrutinib (Synonyms: PCI-32765) |
|---|---|
| CAS | 936563-96-1 |
| Formula | C25H24N6O2 |
| MW | 440.51 |
| Appearance | White powder |
| Storage condition | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). |
Ibrutinib, also known as PCI-32765, is a potent and orally active BTK inhibitor. Ibrutinib binds to and inhibits BTK activity, preventing B-cell activation and B-cell-mediated signaling and inhibiting the growth of malignant B cells that overexpress BTK.